PAA 9.30% 19.5¢ pharmaust limited

Ann: Trading Halt, page-117

  1. 698 Posts.
    lightbulb Created with Sketch. 1324
    No.

    Listing rule 3.1A limits the continuous disclosure obligations provided at listing rule 3.1 by excluding from those obligations various classes of information, including information concerning an incomplete proposal or negotiation.
    So, the scenario you have set out in your post would relate to incomplete proposals or negotiations up until the finalisation of any such negotiations or the award of a grant on funds and, as such, would not be disclosed.
    All of which is irrelevant in any event because, as I clarified for you already, the BoD can take part in a CR (subject of course to SH ratification of the issue of shares to them).
    You cannot read into it what you are trying to - its nonsensical.

    Cheers

    Densy
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.020(9.30%)
Mkt cap ! $86.77M
Open High Low Value Volume
19.5¢ 20.5¢ 19.5¢ $562.4K 2.834M

Buyers (Bids)

No. Vol. Price($)
3 64065 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 115000 2
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.